KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $53,743 | +67.6% | 3,094 | +35.8% | 0.00% | +100.0% |
Q2 2023 | $32,074 | +30.9% | 2,278 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $24,511 | -23.1% | 2,278 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $31,892 | +10.0% | 2,278 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $29,000 | +31.8% | 2,278 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $22,000 | -4.3% | 2,278 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $23,000 | -14.8% | 2,278 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $27,000 | +3.8% | 2,278 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $26,000 | -18.8% | 2,278 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $32,000 | -23.8% | 2,278 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $42,000 | +5.0% | 2,278 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $40,000 | +14.3% | 2,278 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $35,000 | -18.6% | 2,278 | +35.6% | 0.00% | 0.0% |
Q2 2020 | $43,000 | +186.7% | 1,680 | +72.3% | 0.00% | +100.0% |
Q1 2020 | $15,000 | +36.4% | 975 | 0.0% | 0.00% | – |
Q4 2019 | $11,000 | +37.5% | 975 | 0.0% | 0.00% | – |
Q3 2019 | $8,000 | -38.5% | 975 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $13,000 | +30.0% | 975 | +82.2% | 0.00% | – |
Q1 2019 | $10,000 | -33.3% | 535 | 0.0% | 0.00% | -100.0% |
Q4 2018 | $15,000 | +7.1% | 535 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $14,000 | – | 535 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |